AI and automation – often referred to as hyperautomation – are evolving rapidly with industry experts emphasizing their increasing ability to operate independently and make intelligent decisions.

By combining powerful generative AI with business expertise, organizations can accelerate and streamline their processes like never before.

In a recent sit down with Mayank Anand, Vice President of Global Clinical Operations at a leading pharmaceutical company, we discuss the critical role AI and automation play in driving innovation while maintaining quality and trust in drug development.

The pharmaceutical industry is leveraging cutting-edge technology to speed up the delivery of new treatments without compromising transparency or trust. The discussion explores key use cases including data cleansing, synthetic data, digital twins and pharmacoeconomics – demonstrating how AI and automation are enabling faster high-quality outcomes.